Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with rare diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level.

YiTuuX develops and markets artificial intelligence and machine learning based tools to enable healthcare workers.

Development of monoclonal antibody-based therapeutics

Wings Therapeutics is a company dedicated to the development of transformational therapies for patients that suffer from Dystrophic Epidermolysis Bullosa (DEB). The company was founded in 2019 by EB Research partnership and ProQR Therapeutics to continue development of a pipeline of potential RNA therapies for several forms of DEB in a focussed organization. Wings Therapeutics…

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics.

Owner and operator of a biotechnology company intended to focus on developing engineered organisms that safely and effectively treat diseases. The company’s genetically engineered organisms are controlled by small molecules over protein function and by generating biosensors that identify and improve new enzymatic activities, enabling healthcare providers to diagnose the disease easily and give proper…

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology.

Manufactures exoskeletons for spinal injury and industrial applications

Slingshot Bio brings elegant, cost effective solutions to common research and development problems. Their technology makes a significant bottom-line impact on the speed and cost of early-stage discovery and R&D programs.